| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |